In this report

A wave of drugs that harnesses the body’s immune system is fuelling optimism that science is finally closing in on one of its greatest adversaries. Plus: Charles Darwin has suddenly become the most cited scientist in the battle; doctors complaints against the high price of drugs; how society needs to ensure that survivors get their lives back ... and much more

Focus on defence as best form of attack

The stratagem of stimulating the body’s immune system has found its moment

Big pharma back in the game it made

Harnessing a patient’s defence system to attack the disease has prompted excited reaction

Charles Darwin

Blockbuster oncology therapies are outwitted by natural selection

The future of treatment lies in using a range of drugs targeted at the individual patient

Doctors lead backlash against expensive drugs

Critics say there is too much focus on new therapies even when benefits are modest

Funds facing high risks hope for high rewards

With few medicines in early-stage development going on to reach market, the chances of picking a winner are low

Food for thought in the lifestyle changes that can prolong our lives

Relationship between diet and cancer is difficult to establish

Dr Marijn Dekkers, CEO of Bayer AG
©Charlie Bibby

Access to good therapy is big issue for patients in poorer nations

Treatments for diseases other than HIV have had far less attention from big pharma

Allow survivors to get their lives back

Patients who have won the battle against cancer should not face discrimination

Doctors may advise: ‘take your tablet to a consultation’

Patients can use digital technology to find information and get practical support

Therapy thinks small to deliver the heat to stubborn tumours

Microscopic particles take treatments to hard-to-reach places